Cellceutix Corporation-Product Pipeline Review-2015

Cellceutix Corporation-Product Pipeline Review-2015

  • Products Id :- GMDHC06782CDB
  • |
  • Pages: 140
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cellceutix Corporation-Product Pipeline Review-2015


Global Markets Direct's, 'Cellceutix Corporation-Product Pipeline Review-2015', provides an overview of the Cellceutix Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cellceutix Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Cellceutix Corporation including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Cellceutix Corporation's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Cellceutix Corporation's pipeline products

Reasons To Buy

Evaluate Cellceutix Corporation's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Cellceutix Corporation in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Cellceutix Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Cellceutix Corporation and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cellceutix Corporation

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Cellceutix Corporation and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Cellceutix Corporation Snapshot 6

Cellceutix Corporation Overview 6

Key Information 6

Key Facts 6

Cellceutix Corporation-Research and Development Overview 7

Key Therapeutic Areas 7

Cellceutix Corporation-Pipeline Review 13

Pipeline Products by Stage of Development 13

Pipeline Products-Monotherapy 14

Cellceutix Corporation-Pipeline Products Glance 15

Cellceutix Corporation-Clinical Stage Pipeline Products 15

Cellceutix Corporation-Early Stage Pipeline Products 17

Cellceutix Corporation-Drug Profiles 21

brilacidin 21

Kevetrin 23

KM-133 26

CTIX-1278 28

CTIX-1807 29

KM-277 30

KM-278 31

KM-3174 32

KM-362 33

KM-391 34

KM-732 36

PMX-0196 37

PMX-0231 38

PMX-0243 40

PMX-10072 41

PMX-10098 42

PMX-1207 43

PMX-1241 44

PMX-1278 45

PMX-1405 46

PMX-1408 47

PMX-1502 48

PMX-20005 49

PMX-207 50

PMX-225 51

PMX-496 52

PMX-504 53

PMX-519 54

PMX-611 55

PMX-647 56

PMX-835 57

PMX-100 58

PMX-10070 59

PMX-1014 60

PMX-1045 61

PMX-1056 62

PMX-1057 63

PMX-1090 64

PMX-1091 65

PMX-1094 66

PMX-1099 67

PMX-1102 68

PMX-1142 69

PMX-1363 70

PMX-1424 71

PMX-1442 72

PMX-1445 73

PMX-1467 74

PMX-1488 75

PMX-1533 76

PMX-1547 77

PMX-1555 78

PMX-1560 79

PMX-1570 80

PMX-1572 81

PMX-1573 82

PMX-1576 83

PMX-1591 84

PMX-1625 85

PMX-183 86

PMX-223 87

PMX-229 88

PMX-247 89

PMX-255 90

PMX-30016 91

PMX-30024 92

PMX-520 93

PMX-633 94

PMX-668 95

PMX-693 96

PMX-70004 97

PMX-728 98

PMX-741 99

PMX-843 100

PMX-868 101

Cellceutix Corporation-Pipeline Analysis 102

Cellceutix Corporation-Pipeline Products by Target 102

Cellceutix Corporation-Pipeline Products by Route of Administration 103

Cellceutix Corporation-Pipeline Products by Molecule Type 104

Cellceutix Corporation-Pipeline Products by Mechanism of Action 105

Cellceutix Corporation-Recent Pipeline Updates 106

Cellceutix Corporation-Dormant Projects 132

Cellceutix Corporation-Locations And Subsidiaries 133

Head Office 133

Appendix 134

Methodology 134

Coverage 134

Secondary Research 134

Primary Research 134

Expert Panel Validation 134

Contact Us 134

Disclaimer 135

List of Tables

Cellceutix Corporation, Key Information 11

Cellceutix Corporation, Key Facts 11

Cellceutix Corporation-Pipeline by Indication, 2015 13

Cellceutix Corporation-Pipeline by Stage of Development, 2015 18

Cellceutix Corporation-Monotherapy Products in Pipeline, 2015 19

Cellceutix Corporation-Phase II, 2015 20

Cellceutix Corporation-Phase I, 2015 21

Cellceutix Corporation-Preclinical, 2015 22

Cellceutix Corporation-Discovery, 2015 24

Cellceutix Corporation-Pipeline by Target, 2015 107

Cellceutix Corporation-Pipeline by Route of Administration, 2015 108

Cellceutix Corporation-Pipeline by Molecule Type, 2015 109

Cellceutix Corporation-Pipeline Products by Mechanism of Action, 2015 110

Cellceutix Corporation-Recent Pipeline Updates, 2015 111

Cellceutix Corporation-Dormant Developmental Projects,2015 137

List of Figures

Cellceutix Corporation-Pipeline by Top 10 Indication, 2015 13

Cellceutix Corporation-Pipeline by Stage of Development, 2015 18

Cellceutix Corporation-Monotherapy Products in Pipeline, 2015 19

Cellceutix Corporation-Pipeline by Top 10 Target, 2015 107

Cellceutix Corporation-Pipeline by Top 10 Route of Administration, 2015 108

Cellceutix Corporation-Pipeline by Top 10 Molecule Type, 2015 109

Cellceutix Corporation-Pipeline Products by Top 10 Mechanism of Action, 2015 110

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of Cellceutix Corporation; Cellceutix Corporation - Key Therapeutics; Cellceutix Corporation - Pipeline Overview and Promising Molecules; Cellceutix Corporation - News; Cellceutix Corporation - Latest Updates; Cellceutix Corporation - Pipeline; Cellceutix Corporation - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101175
Site License
USD 3000 INR 202350
Corporate User License
USD 4500 INR 303525



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com